GlassScriptPhysician profile
Robin L Brian
NPI 1679858120
$177.28
in general payments reported to CMS, 2019-2025
8 companies · $74.12 in 2025
The $74.12 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.74 · 2023: $29.52 · 2024: $53.90 · 2025: $74.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.71 | 2024-2025 | Vaxneuvance, Vaxelis, M-M-R II |
| Glaxosmithkline, LLC. | $26.47 | 2023-2024 | Bexsero, Flulaval Quadrivalent |
| Tris Pharma INC | $21.79 | 2024 | Dyanavel Xr |
| Sobi, INC | $19.74 | 2022 | |
| Cipher Pharmaceuticals US LLC | $18.65 | 2025 | Spinosad, Natroba |
| Biomarin Pharmaceutical INC. | $18.31 | 2025 | Voxzogo 1.2mg |
| Supernus Pharmaceuticals, INC. | $16.94 | 2025 | Qelbree |
| Cranial Technologies, INC | $16.67 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Brian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.